HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
3.580
-0.010 (-0.28%)
Jun 6, 2025, 4:00 PM - Market closed
HeartSciences Employees
HeartSciences had 15 employees as of April 30, 2024. The number of employees increased by 3 or 25.00% compared to the previous year.
Employees
15
Change (1Y)
3
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$567,804
Market Cap
3.87M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Apr 30, 2024 | 15 | 3 | 25.00% |
| Apr 30, 2023 | 12 | 0 | - |
| Apr 30, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
HSCS News
- 4 days ago - HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis - GlobeNewsWire
- 5 days ago - Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value - GlobeNewsWire
- 10 days ago - HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone - GlobeNewsWire
- 19 days ago - HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025 - GlobeNewsWire
- 4 weeks ago - HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson - GlobeNewsWire
- 4 weeks ago - HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board - GlobeNewsWire
- 5 weeks ago - HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program - GlobeNewsWire
- 3 months ago - HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results - GlobeNewsWire